BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20241218T110000
DTEND;TZID=Europe/Stockholm:20241218T120000
DTSTAMP:20260417T125552
CREATED:20240919T091627Z
LAST-MODIFIED:20240926T111715Z
UID:10001361-1734519600-1734523200@www.scilifelab.se
SUMMARY:IP Strategies for Academic Startups\, Pharma and Biotech Companies in the Life Sciences
DESCRIPTION:Welcome to this Drug Discovery Webinar\, organized by OligoNova and SciLifeLab Drug Discovery and Development. \n\n\n\nThis seminar will build on the previous sessions on regulatory protection and trade secrets\, aiming to provide real world examples of how these approaches can be used to drive the growth of start-ups. Come with your questions and experiences to share! \n\n\n\nregistration\n\n\n\nAgenda \n\n\n\n\nIntroduction – Fredrik Wångsell\, OligoNova\n\n\n\nIP Strategies in the Life Sciences – Fiona Hey\, Tony Proctor and Michel Pears Potter Clarkson\n\n\n\nBio-tech start-up/company that used trade secrets successfully (to be announced)\n\n\n\nInput from your own experiences\n\n\n\nDiscussion\n\n\n\nQ&A\n\n\n\n\nWelcome \n\n\n\nSciLifeLab DDD and OligoNova \n\n\n\nOther Seminars\n\n\n\nOligaNova organizes three seminars during the fall 2024 \n\n\n\nTrade secrets in the Life Sciences\, October 15 \n\n\n\nMaximizing exclusivity in the Life Sciences\, November 6 \n\n\n\nIP Strategies in the Life Sciences\, December 18
URL:https://www.scilifelab.se/event/ip-strategies-in-the-life-sciences/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="OligoNova - Part of the Drug Discovery and Development Platform":MAILTO:par.matsson@oligonova.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20241106T110000
DTEND;TZID=Europe/Stockholm:20241106T120000
DTSTAMP:20260417T125552
CREATED:20240919T091445Z
LAST-MODIFIED:20240926T111706Z
UID:10001360-1730890800-1730894400@www.scilifelab.se
SUMMARY:Maximising exclusivity for Academic Startups\, Pharma and Biotech Companies in the Life Sciences
DESCRIPTION:Welcome to this Drug Discovery Webinar\, organized by OligoNova and SciLifeLab Drug Discovery and Development\, to learn more about how academic and biotech interventions can be protected with the goal to benefit patients. \n\n\n\nJoin us for an insightful seminar focusing on strategies to maximize the exclusivity of medicinal products in the marketplace.  This session will delve into the intricacies of regulatory intellectual property (IP)\, including patenting strategies\, patent term extensions such as Supplementary Protection Certificates (SPCs)\, and regulatory exclusivities like data and market exclusivity. Additionally\, we will explore further exclusivities available for orphan and paediatric medicines. \n\n\n\nThe seminar will emphasise the critical role of exclusivity in attracting and securing investor interest. Gain valuable knowledge on how to navigate and leverage these mechanisms to extend the market life of your medicinal products effectively\, thereby enhancing their appeal to potential investors. \n\n\n\nregistration\n\n\n\nAgenda \n\n\n\n\nIntroduction – Fredrik Wångsell\, OligoNova\n\n\n\nMaximizing exclusivity in the Life Sciences – Fiona Hey\, Tony Proctor and Michel Pears\, Potter Clarkson\n\n\n\nQ&A and discussion\n\n\n\n\nOne follow-up webinar will take place later this year <ADD LINK> \n\n\n\nWelcome \n\n\n\nSciLifeLab DDD and OligoNova \n\n\n\nOther Seminars\n\n\n\nOligaNova organizes three seminars during the fall 2024 \n\n\n\nTrade secrets in the Life Sciences\, October 15 \n\n\n\nMaximizing exclusivity in the Life Sciences\, November 6 \n\n\n\nIP Strategies in the Life Sciences\, December 18
URL:https://www.scilifelab.se/event/maximizing-exclusivity-in-the-life-sciences/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="OligoNova - Part of the Drug Discovery and Development Platform":MAILTO:par.matsson@oligonova.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20241015T110000
DTEND;TZID=Europe/Stockholm:20241015T120000
DTSTAMP:20260417T125552
CREATED:20240919T090941Z
LAST-MODIFIED:20240926T111646Z
UID:10001359-1728990000-1728993600@www.scilifelab.se
SUMMARY:Trade secrets for Academic Startups\, Pharma and Biotech Companies in the Life Sciences
DESCRIPTION:Welcome to this Drug Discovery Webinar\, organized by OligoNova and SciLifeLab Drug Discovery and Development\, to learn more about how academic and biotech interventions can be protected with the goal to benefit patients. \n\n\n\nThis webinar is an introduction to trade secrets as a form of intellectual property\, with a focus on its potential importance to a life sciences start up.   \n\n\n\nTrade secrets are often an overlooked form of intellectual property\, thought by many to be of little relevance in the life sciences.  However\, as part of a well-developed IP strategy\, trade secrets have an increasingly important role to play\, with the potential to not only supplement a patent-based strategy but\, in some cases\, to provide a more suitable alternative. \n\n\n\nIn this seminar\, we will discuss how trade secrets can be identified\, protected\, and used to increase value and support investment. \n\n\n\nregistration\n\n\n\nAgenda \n\n\n\n\nIntroduction – Fredrik Wångsell\, OligoNova\n\n\n\nTrade secrets in the Life Sciences – Fiona Hey\, Tony Proctor and Michel\, Pears Potter Clarkson\n\n\n\nQ&A and discussion\n\n\n\n\nWelcome \n\n\n\nSciLifeLab DDD and OligoNova \n\n\n\nOther Seminars\n\n\n\nOligaNova organizes three seminars during the fall 2024 \n\n\n\nTrade secrets in the Life Sciences\, October 15 \n\n\n\nMaximizing exclusivity in the Life Sciences\, November 6 \n\n\n\nIP Strategies in the Life Sciences\, December 18
URL:https://www.scilifelab.se/event/trade-secrets-in-the-life-sciences/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="OligoNova - Part of the Drug Discovery and Development Platform":MAILTO:par.matsson@oligonova.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240409T130000
DTEND;TZID=Europe/Stockholm:20240409T150000
DTSTAMP:20260417T125552
CREATED:20240212T162122Z
LAST-MODIFIED:20240226T142053Z
UID:10001153-1712667600-1712674800@www.scilifelab.se
SUMMARY:Patentability and Strategies for Novel Therapeutic Oligonucleotides
DESCRIPTION:Welcome to this seminar to learn more about intellectual properties regarding therapeutic oligonucleotides and strategies how to protect your invention. The seminar is organized by OligoNova Hub and SciLifeLab Drug Discovery and Development and is a hybrid event (Zoom or in-person at GoCo House).    \n\n\n\nAgenda \n\n\n\nIntroduction \n\n\n\n\nOligoNova Hub/ScilifeLab DDD: Pär Matsson\, 5 min\n\n\n\nAstraZeneca: Peter Storm 20 min\n\n\n\nRibocure: (TBC) 20 min\n\n\n\n\nPatentability and Strategies for Therapeutic Oligonucleotides \n\n\n\n\nPotter Clarkson: Fiona Hey\, Kevin Rich and Louise Tottie\n\n\n\n\nPanel discussion questions  \n\n\n\n\nModerator: OligoNova Hub/DDD\n\n\n\n\nModerator: OligoNova Hub/DDD \n\n\n\nProtecting your innovation and future proofing your enterprise may well mean the difference between commercial success and disappointment. However\, it is not always obvious what IP you have\, what you might be able to protect and what is worthwhile protecting.  With a focus on oligonucleotide inventions\, we will guide you through the requirements for patentability\, highlighting the challenges associated with oligonucleotides and outlining an IP strategy that you can apply to help you to achieve your commercial goals. \n\n\n\nFor those that attend the seminar in person\, there will be time to continue the discussion after the program with IP attorneys and academic and industrial scientist working with therapeutic oligonucleotides. Coffee and cake will be served. \n\n\n\nPrior this hybrid event there will be a more general webinar (March 25\, at 1 pm) “Patent Fundamentals for Academia and Biotech Inventions”. \n\n\n\nOligoNova Hub offers industry-standard research and development capabilities to Swedish academic researchers\, helping to transform their ideas into new oligonucleotide therapies. OligoNova Hub is part of the national SciLifeLab Drug Discovery and Development infrastructure\, supporting academic researchers in drug discovery and development towards innovative commercial assets that will benefit patients. \n\n\n\n \n\n\n\nRegistration \n\n\n\nregistration\n\n\n\nOrganizer \n\n\n\nFredrik Wångsell\, Research Advisor at OligoNova Hub/SciLifeLab Oligonucleotide Therapeutics Unit
URL:https://www.scilifelab.se/event/patentability-and-strategies-for-novel-therapeutic-oligonucleotides/
LOCATION:GoCo House\, Allvar Gullstrand\, Entreprenörsstråket 10\, Mölndal\, 431 53\, Sweden
CATEGORIES:Event
ORGANIZER;CN="OligoNova - Part of the Drug Discovery and Development Platform":MAILTO:par.matsson@oligonova.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240325T130000
DTEND;TZID=Europe/Stockholm:20240325T140000
DTSTAMP:20260417T125552
CREATED:20240215T110446Z
LAST-MODIFIED:20240222T102726Z
UID:10001156-1711371600-1711375200@www.scilifelab.se
SUMMARY:Patent Fundamentals for Biotech Inventions
DESCRIPTION:Welcome to this webinar\, organized by OligoNova and SciLifeLab Drug Discovery and Development\, to learn more about how academic and biotech interventions can be protected with the goal to benefit patients. Understanding what can be claimed in a patent application\, what data is needed\, the patenting process\, who owns an invention\, and whether one has freedom to operate can be challenging. A strong intervention of early projects is one part needed to be as attractive as possible for the way forward in drug development. In this webinar\, Fiona Hey\, Kevin Rich and Louise Tottie from Potter Clarkson will guide you through these fundamental topics in preparation for our second seminar\, focused on therapeutic oligonucleotide inventions\, April 9\, Patentability and Strategies for Therapeutic Oligonucleotides \n\n\n\nAgenda \n\n\n\n\nIntroduction\n\n\n\nOligoNova\, 5 min\n\n\n\nPatent Fundamentals for Academic and Biotech Inventions\n\n\n\nPotter Clarkson: Fiona Hey\, Kevin Rich and Louise Tottie\, 60 min\n\n\n\nQ&A: 25 min moderated by OligoNova\n\n\n\n\nSpeakers\n\n\n\n\nFredrik Wångsell\, OligoNova Hub/SciLifeLab\n\n\n\nFiona Hey\, Potter Clarkson\n\n\n\nKevin Rich\, Potter Clarkson\n\n\n\nLouise Tottie\, Potter Clarkson\n\n\n\n\nRegistration
URL:https://www.scilifelab.se/event/patent-fundamentals-for-biotech-inventions/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="OligoNova - Part of the Drug Discovery and Development Platform":MAILTO:par.matsson@oligonova.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220404T140000
DTEND;TZID=Europe/Stockholm:20220404T150000
DTSTAMP:20260417T125552
CREATED:20220316T072135Z
LAST-MODIFIED:20220331T055237Z
UID:10000559-1649080800-1649084400@www.scilifelab.se
SUMMARY:Information meeting – Call for Therapeutic Oligonucleotide Projects at OligoNova Hub / SciLifeLab DDD
DESCRIPTION:The mission of the Drug Discovery and Development Platform at SciLifeLab is to support researchers in developing new drugs\, transforming academic ideas into new treatments. Therapeutic oligonucleotides is a recent addition to the Drug Discovery and Development platform’s capacity\, available through the OligoNova Hub in Gothenburg.  \n\n\n\nNow\, the first call for therapeutic oligonucleotide projects is opening (March 28 – May 13\, 2022). \n\n\n\nAt this online information meeting\, there will be a presentation of the call and you as an applicant will have the opportunity to ask questions about the call and the application process.  \n\n\n\nThe call text will be published via the SciLifeLab and OligoNova websites on March 28. \n\n\n\nRegister here\n\n\n\n\n\n\n\nOligoNova Hub is a national facility providing academic researchers in Sweden with support and capabilities to convert ideas and discoveries into potential new oligonucleotide therapies. OligoNova Hub is part of the SciLifeLab Drug Discovery and Development platform\, and is located at the AZ BioVentureHub campus in Gothenburg. The OligoNova Hub offers full capacity for the design\, synthesis\, evaluation and optimization of therapeutic oligonucleotides to academic researchers. The hub has been made possible through support from the Knut and Alice Wallenberg foundation\, SciLifeLab\, University of Gothenburg\, Region Västra Götaland\, and a donation from Carl Bennet.
URL:https://www.scilifelab.se/event/information-meeting-call-for-therapeutic-oligonucleotide-projects-at-oligonova-hub-scilifelab-ddd/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="OligoNova - Part of the Drug Discovery and Development Platform":MAILTO:par.matsson@oligonova.org
END:VEVENT
END:VCALENDAR